期刊
ANTIOXIDANTS & REDOX SIGNALING
卷 37, 期 1-3, 页码 115-134出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2021.0072
关键词
blood-brain barrier; blood components; inflammatory response; intracerebral hemorrhage; oxidative stress
资金
- National Natural Science Foundation of China [82001389, 851901250, 81971222, 81471340]
- Natural Science Foundation of Guangdong Province [2019A1515010104]
- High-level Hospital Construction Project of Guangdong Provincial People's Hospital [DFJH201924]
This review examines the breakdown of the blood-brain barrier (BBB) after intracerebral hemorrhage (ICH) and focuses on strategies to protect the BBB integrity and potential therapeutic targets.
Significance: Blood-brain barrier (BBB) disruption is a major pathological change after intracerebral hemorrhage (ICH) and is both the cause and result of oxidative stress and of the immune response post-ICH. These processes contribute to ICH-induced brain injury.Recent Advances: After the breakdown of cerebral vessels, blood components, including erythrocytes and their metabolites, thrombin, and fibrinogen, can access the cerebral parenchyma through the compromised BBB, triggering oxidative stress and inflammatory cascades. These aggravate BBB disruption and contribute to further infiltration of blood components, resulting in a vicious cycle that exacerbates brain edema and neurological injury after ICH. Experimental and clinical studies have highlighted the role of BBB disruption in ICH-induced brain injury.Critical Issues: In this review, we focus on the strategies to protect the BBB in ICH. Specifically, we summarize the evidence and the underlying mechanisms, including the ICH-induced process of oxidative stress and inflammatory response, and we highlight the potential therapeutic targets to protect BBB integrity after ICH.Future Directions: Future studies should probe the mechanism of ferroptosis as well as oxidative stress-inflammation coupling in BBB disruption after ICH and investigate the effects of antioxidants and immunomodulatory agents in more ICH clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据